Andreas Niethammer, M.D., Ph.D.
Executive Medical Director
Dr. Niethammer has served in the clinical development group since 2015 and is a board certified Radiation Oncologist and Immunologist. Dr. Niethammer remains an associate professor of Experimental Oncology at the University of Heidelberg, Germany, where he practiced oncology until 2007. Prior to joining NantKwest, he held several Vice President and senior level positions in pharmaceutical companies including Pfizer, Eli Lilly, Tocagen and Poseida. Dr. Niethammer is also a cofounder of Vaximm, a clinical stage company focusing on therapeutic vaccines based on his inventions. Dr. Niethammer received his medical and scientific training at the Universities of Heidelberg, Brown University, University of California, Los Angeles and the Scripps Research Institute in La Jolla. He holds multiple patents and is the recipient of numerous awards and grants.